PI3K

Phosphoinositide 3-kinases (PI3Ks) are lipid kinases that catalyze the phosphorylation of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P₂) to generate the second messenger phosphatidylinositol (3,4,5)-trisphosphate (PI(3,4,5)P₃). The production of PI(3,4,5)P₃ facilitates the recruitment and activation of pleckstrin homology (PH) domain–containing proteins at the plasma membrane, thereby initiating downstream signaling cascades essential for cellular proliferation, survival, and migration.

PI3Ks are divided into three major classes, among which Class I PI3Ks are most prominently implicated in cancer biology. Class I enzymes comprise four distinct catalytic isoforms: PI3Kα, PI3Kβ, PI3Kδ, and PI3Kγ.

Class IA PI3Ks, the subclass most commonly associated with oncogenic signaling, function as heterodimeric lipid kinases composed of a catalytic p110 subunit (p110α, p110β, or p110δ, encoded by PIK3CA, PIK3CB, and PIK3CD, respectively) and a regulatory p85 subunit.

The PI3K signaling pathway plays a central role in diverse biological processes, including cell cycle progression, cellular growth, survival, actin cytoskeletal rearrangement, migration, and intracellular vesicular trafficking.

Frequently Asked Questions
Phosphoinositide 3-kinases (PI3Ks) are a family of lipid kinases that phosphorylate phosphatidylinositol lipids to regulate cell growth, survival, metabolism, and immune signaling. PI3K activation leads to downstream AKT and mTOR pathway signaling. Aberrant PI3K signaling is frequently observed in cancer due to PIK3CA mutations, PTEN loss, or receptor tyrosine kinase activation.
Class I PI3Ks include four catalytic isoforms: PI3Kα (PIK3CA) PI3Kβ (PIK3CB) PI3Kδ (PIK3CD) PI3Kγ (PIK3CG) PI3Kα and β are broadly expressed, while PI3Kδ and γ are enriched in leukocytes and play critical roles in immune regulation. Isoform selectivity is an important consideration in drug development due to toxicity and immune effects.
PI3K inhibitors can be classified as: Pan-PI3K inhibitors Isoform-selective inhibitors (α, β, δ, γ) Dual PI3K/mTOR inhibitors Irreversible inhibitors Selectivity influences therapeutic window and toxicity profile.
While PI3K inhibitors block upstream lipid kinase activity, mTOR inhibitors act downstream at the level of mTORC1 or mTORC2. Dual PI3K/mTOR inhibitors target both nodes of the pathway and may achieve broader pathway suppression.

Items 251-275 of 369

  • PI3K/mTOR Inhibitor-3
    Cat. No.
    A79734

    PI3K/mTOR Inhibitor-3

    PI3K/mTOR Inhibitor-3 is a potent dual inhibitor of phosphoinositide 3-kinase (PI3K) and mechanistic target of rapamycin (mTOR). This imidazoline derivative exhibits significant anti-cancer activity, making it a valuable tool for cancer research. Its ability to modulate key signaling pathways related to cell growth and survival enhances its utility in studying tumor biology and therapeutic strategies.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • PI3Kα-IN-5
    Cat. No.
    A79735

    PI3Kα-IN-5

    PI3Kα-IN-5 is a potent inhibitor of the PI3Kα and mTOR pathways, exhibiting IC50 values of 0.7 nM and 3.3 nM, respectively. This compound is valuable for research focused on colorectal cancer, offering insights into the modulation of these critical signaling pathways. Its specificity and efficacy make it an important tool for investigating the roles of PI3Kα and mTOR in cancer biology.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • PI3K/mTOR Inhibitor-12
    Cat. No.
    A79739

    PI3K/mTOR Inhibitor-12

    PI3K/mTOR Inhibitor-12 is a selective inhibitor targeting the phosphoinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR) pathways, exhibiting IC50 values of 0.06 nM for PI3Kα and 3.12 nM for mTOR. This compound demonstrates significant antitumor activity, making it a valuable tool for cancer research. Additionally, PI3K/mTOR Inhibitor-12 has been shown to possess reduced liver toxicity, enhancing its potential for therapeutic applications in oncology.

    25 mg
    $1,405.00
    50 mg
    $1,790.00
    All 3 sizes
  • PI3K/mTOR Inhibitor-8
    Cat. No.
    A79742

    PI3K/mTOR Inhibitor-8

    PI3K/mTOR Inhibitor-8 is a potent dual inhibitor of PI3K and mTOR, exhibiting IC50 values of 0.46 nM and 12 nM against PI3Kα and mTOR, respectively. This compound promotes apoptosis in HCT-116 cells and effectively induces cell cycle arrest at the G1/S phase. It serves as a valuable tool for researchers investigating the roles of PI3K and mTOR signaling in cancer biology and potential therapeutic interventions.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • MCX 28
    Cat. No.
    A79745

    MCX 28

    MCX 28 is a potent inhibitor of the phosphoinositide 3-kinase (PI3K) pathway, functioning as a triple inhibitor of PI3K, mTOR, and PIM kinases. It exhibits low nanomolar activity, making it a valuable tool for studying signaling pathways involved in cancer and other diseases. This compound is particularly useful for research applications focused on the modulation of cell proliferation, survival, and metabolic processes.

    5 mg
    $795.00
    All 1 sizes
  • PI3K/mTOR-IN-18
    Cat. No.
    A79748

    PI3K/mTOR-IN-18

    PI3K/mTOR-IN-18 is a highly selective dual inhibitor targeting PI3Kα and mTOR, with binding affinities of Ki=0.130 nM and Ki=0.111 nM, respectively. This compound effectively blocks the PI3K/AKT/mTOR signaling pathway, resulting in significant inhibition of tumor cell proliferation (IC50=144 nM). PI3K/mTOR-IN-18 is suitable for research involving various solid tumors, including breast cancer and non-small cell lung cancer (NSCLC).

    Out of stock

    All 3 sizes
  • PI3K/mTOR Inhibitor-14
    Cat. No.
    A79749

    PI3K/mTOR Inhibitor-14

    PI3K/mTOR Inhibitor-14 is a dual inhibitor targeting phosphoinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR), exhibiting IC50 values of 171.4 nM and 10.1 nM, respectively. This compound demonstrates significant antitumor activity, making it a valuable tool for cancer research. Its inhibition of the PI3K/mTOR signaling pathway can be critical for studies focused on cell proliferation and survival in various cancer models.

    Out of stock

    All 3 sizes
  • PI3K/mTOR Inhibitor-7
    Cat. No.
    A79750

    PI3K/mTOR Inhibitor-7

    PI3K/mTOR Inhibitor-7 (Compound 19i) is a potent dual inhibitor targeting the PI3K and mTOR pathways. It demonstrates a 4.7-fold increased potency compared to the positive control gedatolisib, with an IC50 of 0.3 μM. At a concentration of 10 μM, PI3K/mTOR Inhibitor-7 effectively suppresses the PI3K/Akt/mTOR signaling pathway. This compound is valuable for research applications focused on cancer biology and related therapeutic development.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • PI3K/mTOR Inhibitor-6
    Cat. No.
    A79753

    PI3K/mTOR Inhibitor-6

    PI3K/mTOR Inhibitor-6 is a potent dual inhibitor targeting the phosphoinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR) pathways. This compound demonstrates enhanced stability in artificial gastric fluids compared to other PI3K/mTOR inhibitors. At a concentration of 10 μM, PI3K/mTOR Inhibitor-6 effectively suppresses the PI3K/Akt/mTOR signaling pathway, highlighting its potential for cancer research applications.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • PI-540
    Cat. No.
    A79755

    PI-540

    PI-540 is a bicyclic thienopyrimidine derivative that functions as an orally active inhibitor of phosphoinositide 3-kinases (PI3K). Demonstrating potent anti-cancer cell proliferation activity, PI-540 selectively inhibits various PI3K isoforms with IC50 values of 10 nM for P110α, 3510 nM for P110β, 410 nM for P110δ, and 33110 nM for P110γ. In addition to its PI3K inhibition, PI-540 also targets mTOR and DNA-PK, with IC50 values of 61 nM and 525 nM, respectively, making it a valuable tool for cancer research and therapeutic development.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • CC-M-1
    Cat. No.
    A79756

    CC-M-1

    CC-M-1 is a potent and selective inhibitor of the PI3K/mTOR signaling pathway, targeting PI3Kα/β/γ/δ and mTOR with IC50 values of 0.68, 1.02, 1.03, 8.03, and 15 nM, respectively. This compound demonstrates significant inhibition of proliferation in colorectal cancer cell lines, including HCT-116 (IC50 = 0.38 μM) and HT-29 (IC50 = 1.70 μM). CC-M-1 serves as a valuable tool for researchers investigating colorectal cancer (CRC) therapeutic strategies and the underlying mechanisms of tumorigenesis.

    Out of stock

    All 3 sizes
  • PI3K/mTOR Inhibitor-13
    Cat. No.
    A79757

    PI3K/mTOR Inhibitor-13

    PI3K/mTOR Inhibitor-13 is a potent, orally active dual inhibitor targeting phosphoinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR). This compound demonstrates significant biological activity against various pathologies, including solid tumors, sexual diseases, and idiopathic pulmonary fibrosis (IPF). It serves as a valuable tool for cancer research and therapeutic development related to these conditions.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • WJD008
    Cat. No.
    A79768

    WJD008

    WJD008 is a potent dual inhibitor of phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR), specifically targeting PI3K α and mTOR kinase activities. It exhibits significant antiproliferative and anticlonogenic effects in tumor cells, particularly those with PIK3CA mutations. By disrupting the insulin-like growth factor-I-activated PI3K-Akt-mTOR signaling pathway, WJD008 holds promise for advancing cancer research and therapeutic strategies.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • PI3K-IN-30
    Cat. No.
    A79783

    PI3K-IN-30

    PI3K-IN-30 is a selective inhibitor of phosphoinositide 3-kinases (PI3Ks), demonstrating potent inhibition with IC50 values of 5.1 nM for PI3Kα, 136 nM for PI3Kβ, 30.7 nM for PI3Kγ, and 8.9 nM for PI3Kδ. This compound is suitable for studies investigating PI3K signaling pathways and their implications in cancer and other diseases. Its high specificity and potency make it a valuable tool for biochemical and cellular research focused on PI3K-related mechanisms.

    2 mg
    $80.00
    5 mg
    $125.00
    All 6 sizes
  • Roginolisib
    Cat. No.
    A79784

    Roginolisib

    Synonyms: MSC2360844; IOA-244

    Roginolisib is a selective PI3Kδ inhibitor that exhibits potent activity with an IC50 of 145 nM. This compound demonstrates high selectivity against a broad panel of 278 additional kinases, making it a valuable tool for research in cell signaling pathways. Its application in studies targeting immune responses and cancer biology highlights the importance of PI3Kδ modulation in therapeutic development.

    1 mg
    $40.00
    5 mg
    $95.00
    All 7 sizes
  • PI3Kγ inhibitor AZ2
    Cat. No.
    A79786

    PI3Kγ inhibitor AZ2

    PI3Kγ inhibitor AZ2 selectively targets phosphoinositide 3-kinase gamma (PI3Kγ) with a pIC50 value of 9.3, indicating potent inhibition. This compound is valuable for investigating the role of PI3Kγ in inflammatory and immune diseases, providing insights into potential therapeutic applications. Its specificity makes it a useful tool in biochemical and pharmacological studies related to immune regulation.

    1 mg
    $80.00
    5 mg
    $205.00
    All 6 sizes
  • AMG 511
    Cat. No.
    A79787

    AMG 511

    AMG 511 is a potent pan-inhibitor of class I phosphoinositide 3-kinases (PI3Ks), demonstrating inhibitory constants (Kis) of 4 nM, 6 nM, 2 nM, and 1 nM for PI3Kα, β, δ, and γ, respectively. This compound effectively suppresses PI3K signaling, as evidenced by a decrease in phosphorylated Akt (Ser473). AMG 511 has shown significant anti-tumor activity in mouse models of glioblastoma, making it a valuable tool for cancer research and therapeutic development.

    1 mg
    $65.00
    2 mg
    $90.00
    All 3 sizes
  • Duvelisib (R enantiomer)
    Cat. No.
    A79788

    Duvelisib (R enantiomer)

    Synonyms: IPI-145 R enantiomer; INK1197 R enantiomer

    Duvelisib (R enantiomer) is a selective inhibitor of phosphoinositide 3-kinase (PI3K), targeting the delta and gamma isoforms. It exhibits antitumor activity by inhibiting cell proliferation and promoting apoptosis in various cancer models. This compound is primarily utilized in research focused on cancer treatment, immune response modulation, and signaling pathway analysis.

    5 mg
    $80.00
    10 mg
    $120.00
    All 5 sizes
  • PF-06843195
    Cat. No.
    A79789

    PF-06843195

    PF-06843195 is a highly selective inhibitor of the PI3Kα isoform, exhibiting an IC50 of 18 nM in Rat1 fibroblasts. With kinase inhibition constants (Kis) of less than 0.018 nM and 0.28 nM for PI3Kα and PI3Kδ respectively, this compound effectively suppresses the PI3K/mTOR signaling pathway. PF-06843195 demonstrates significant antitumor efficacy, making it a valuable tool for research applications targeting cancer biology and therapeutic development.

    2 mg
    $25.00
    5 mg
    $65.00
    All 3 sizes
  • MIPS-21335
    Cat. No.
    A79790

    MIPS-21335

    MIPS-21335 is a selective inhibitor of PI3KC2α, exhibiting an IC50 value of 7 nM. Additionally, it demonstrates inhibition of PI3KC2β, p110α, p110β, and p110δ, with corresponding IC50 values of 43, 140, 386, and 742 nM. MIPS-21335 exhibits significant antithrombotic effects and is valuable for research into cardiovascular and metabolic diseases, including thrombosis and hyperlipidemia.

    5 mg
    $305.00
    10 mg
    $505.00
    All 4 sizes
  • AZD8154
    Cat. No.
    A79792

    AZD8154

    AZD8154 is a selective dual inhibitor of the PI3Kγ and PI3Kδ isoforms. By effectively suppressing the activation of these signaling pathways, AZD8154 demonstrates potential in modulating inflammatory responses. This reagent is suitable for research in inflammation and immunology, particularly in studies related to asthma and other related conditions.

    5 mg
    $535.00
    10 mg
    $825.00
    All 5 sizes
  • PIT-1
    Cat. No.
    A79793

    PIT-1

    PIT-1 is a selective inhibitor of phosphatidylinositol 3,4,5-trisphosphate (PIP3) that targets the PI3K/Akt signaling pathway. By inhibiting PIP3, PIT-1 effectively disrupts cancer cell survival and promotes apoptosis. This compound demonstrates significant antitumor activity in vivo, making it suitable for investigations into cancer therapeutics and signaling pathways involved in oncogenesis.

    5 mg
    $25.00
    10 mg
    $30.00
    All 5 sizes
  • (S)-Tersolisib
    Cat. No.
    A79795

    (S)-Tersolisib

    Synonyms: (S)-STX-478; (S)-STX-478-101; (S)-LY4064809

    (S)-Tersolisib is the S-enantiomer of STX-478, a selective inhibitor of PI3Kα mutants. This compound effectively prevents metabolic dysfunction and exhibits notable antitumor activity in xenograft mouse models harboring PI3Kα mutant tumors. It serves as a valuable research tool for studying the therapeutic potential of targeting PI3Kα mutations in cancer.

    1 mg
    $60.00
    5 mg
    $135.00
    All 6 sizes
  • Leniolisib phosphate
    Cat. No.
    A79796

    Leniolisib phosphate

    Synonyms: CDZ173 phosphate

    Leniolisib phosphate is a potent and selective inhibitor of the phosphoinositide 3-kinase delta (PI3Kδ) pathway. This compound exhibits significant biological activity in modulating immune responses, making it a valuable tool for research in immunodeficiency disorders. Its mechanism of action underscores its potential in therapeutic applications targeting underlying immunological defects.

    5 mg
    $170.00
    10 mg
    $295.00
    All 5 sizes
  • PI3K-IN-31
    Cat. No.
    A79797

    PI3K-IN-31

    PI3K-IN-31 is a potent inhibitor of phosphoinositide 3-kinases (PI3K), displaying IC50 values of 3.7 nM for PI3Kα, 74 nM for PI3Kβ, 14.6 nM for PI3Kγ, and 9.9 nM for PI3Kδ. Its selective inhibition of these kinases correlates with significant anticancer activity, making it a valuable tool in cancer research. Applications for PI3K-IN-31 include studying the PI3K signaling pathway and evaluating its role in tumorigenesis and therapeutic resistance.

    5 mg
    $105.00
    10 mg
    $185.00
    All 5 sizes

Items 251-275 of 369

Added to your cart

View Cart Checkout

    Loading...